Debrah Thompson

Title: Debrah Thompson: Innovator in Nucleic Acid Target Sequencing

Introduction

Debrah Thompson is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of molecular diagnostics, particularly in the area of nucleic acid sequencing. With a total of 2 patents, her work has advanced the methodologies used in genetic analysis.

Latest Patents

Debrah's latest patents include a "Method of direct target sequencing using nuclease protection." This patent provides methods and kits for direct sequencing of nucleic acid targets, allowing for the determination of the presence of one or more nucleic acid targets in a sample. Another notable patent is for "Quantitative nuclease protection assay (QNPA) and sequencing (QNPS) improvements." This patent offers enhancements to quantitative Nuclease Protection Assay (qNPA) and quantitative Nuclease Protection Sequencing (qNPS) methods. The disclosed methods utilize nuclease protection probes (NPPs) that include 5'-end and/or 3'-end flanking sequences, facilitating universal hybridization and/or amplification sequences.

Career Highlights

Debrah Thompson is currently associated with Htg Molecular Diagnostics, Inc., where she continues to innovate in the field of molecular diagnostics. Her work has been instrumental in developing techniques that improve the accuracy and efficiency of nucleic acid detection.

Collaborations

Throughout her career, Debrah has collaborated with notable colleagues such as Bruce Seligmann and Tom Vasicek. These partnerships have contributed to the advancement of her research and the successful implementation of her patented technologies.

Conclusion

Debrah Thompson's contributions to nucleic acid target sequencing have established her as a key figure in molecular diagnostics. Her innovative patents and collaborative efforts continue to influence the field significantly.